Literature DB >> 15456754

Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap.

Isabelle Isnardi1, Renaud Lesourne, Pierre Bruhns, Wolf H Fridman, John C Cambier, Marc Daëron.   

Abstract

FcgammaRIIB are low-affinity receptors for IgG that contain an immunoreceptor tyrosine-based inhibition motif (ITIM) and inhibit immunoreceptor tyrosine-based activation motif (ITAM)-dependent cell activation. When coaggregated with ITAM-bearing receptors, FcgammaRIIB become tyrosyl-phosphorylated and recruit the Src homology 2 (SH2) domain-containing inositol 5'-phosphatases SHIP1 and SHIP2, which mediate inhibition. The FcgammaRIIB ITIM was proposed to be necessary and sufficient for recruiting SHIP1/2. We show here that a second tyrosine-containing motif in the intracytoplasmic domain of FcgammaRIIB is required for SHIP1/2 to be coprecipitated with the receptor. This motif functions as a docking site for the SH2 domain-containing adapters Grb2 and Grap. These adapters interact via their C-terminal SH3 domain with SHIP1/2 to form a stable receptor-phosphatase-adapter trimolecular complex. Both Grb2 and Grap are required for an optimal coprecipitation of SHIP with FcgammaRIIB, but one adapter is sufficient for the phosphatase to coprecipitate in a detectable manner with the receptors. In addition to facilitating the recruitment of SHIPs, the second tyrosine-based motif may confer upon FcgammaRIIB the properties of scaffold proteins capable of altering the composition and stability of the signaling complexes generated following receptor engagement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456754     DOI: 10.1074/jbc.M410261200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Functional divergence of Kaposi's sarcoma-associated herpesvirus and related gamma-2 herpesvirus thymidine kinases: novel cytoplasmic phosphoproteins that alter cellular morphology and disrupt adhesion.

Authors:  Michael B Gill; Jo-Ellen Murphy; Joyce D Fingeroth
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.

Authors:  Jens Ruschmann; Frann Antignano; Vivian Lam; Kim Snyder; Connie Kim; Martha Essak; Angela Zhang; Ann Hsu-An Lin; Raghuveer Singh Mali; Reuben Kapur; Gerald Krystal
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

3.  Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in Fc epsilon RI-dependent mast cell activation.

Authors:  Damiana Alvarez-Errico; Yumi Yamashita; Ryo Suzuki; Sandra Odom; Yasuko Furumoto; Toshiyuki Yamashita; Juan Rivera
Journal:  J Immunol       Date:  2010-03-22       Impact factor: 5.422

Review 4.  Adapters in the organization of mast cell signaling.

Authors:  Damiana Alvarez-Errico; Eva Lessmann; Juan Rivera
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

5.  Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor.

Authors:  Simon Lumb; Sarah J Fleischer; Annika Wiedemann; Capucine Daridon; Alison Maloney; Anthony Shock; Thomas Dörner
Journal:  J Cell Commun Signal       Date:  2016-04-28       Impact factor: 5.782

Review 6.  Regulation of hematopoietic cell function by inhibitory immunoglobulin G receptors and their inositol lipid phosphatase effectors.

Authors:  Carol T Cady; Jeffrey S Rice; Vanessa L Ott; John C Cambier
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

Review 7.  Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.

Authors:  Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

8.  Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP.

Authors:  Kishore V L Parsa; Latha P Ganesan; Murugesan V S Rajaram; Mikhail A Gavrilin; Ashwin Balagopal; Nrusingh P Mohapatra; Mark D Wewers; Larry S Schlesinger; John S Gunn; Susheela Tridandapani
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

9.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

10.  Activation/Inhibition of mast cells by supra-optimal antigen concentrations.

Authors:  Michael Huber
Journal:  Cell Commun Signal       Date:  2013-01-22       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.